Axsome Therapeutics Inc (AXSM)
83.80
+0.02
(+0.02%)
USD |
NASDAQ |
Jan 08, 14:23
Axsome Therapeutics Shareholders Equity (Quarterly): 92.90M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp | 2.017B |
| Pfizer Inc | 92.29B |
| Marinus Pharmaceuticals Inc | -66.74M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 561.46M |
| Total Liabilities (Quarterly) | 468.56M |
| Debt to Equity Ratio | 1.938 |
| Current Ratio | 2.442 |
| Net Debt Paydown Yield | -0.01% |